EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo‐Oophorectomy in BRCA1 /2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center

Sara Mendes iD, Maryam Yahiaoui-Doktor, Eva Maria Fallenberg, Marion Kiechle iD, Sabine Grill

Cancer Medicine · 2026-03 · 15 (3)

DOI: 10.1002/cam4.71691 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Medicine, online erschienen am 09.03.2026. Verfasst von Sara Mendes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University Hospital Klinikum Rechts der Isar, Technical University Munich (TUM), Munich, Germany. Hauptthemen laut MEDLINE: Salpingo-oophorectomy, Ovarian Neoplasms, Germ-Line Mutation, Breast Neoplasms. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As the data on BRCA1/2 ‐associated breast and ovarian cancer prevalence after prophylactic surgery has not been exhaustively investigated yet, we aimed to evaluate the cancer prevalence in a single center cohort of BRCA1 and BRCA2 carriers after conducting prophylactic mastectomy, as well as prophylactic bilateral salpingo‐oophorectomy (PBSO) respectively.

Methods

We included 875 women that were tested positive for a germline variant in the BRCA1/BRCA2 gene (gPV) between 2002 and 2022 at the Center of Hereditary Breast and Ovarian Cancer of the Technical University Munich Germany. Mean follow up was 7.2 years (range 0–44 years; 95% CI: 6.70 to 7.70). We differentiated breast and/or ovarian cancer diseased ( n = 643) and non‐diseased BRCA1/2 carriers ( n = 232).

Results

Our analysis confirmed the effectiveness of prophylactic surgeries in genetically predisposed women with a gPV in the BRCA1 /2 gene. We observed no breast cancer after prophylactic bilateral mastectomy, 2 contralateral breast cancer diseases after contralateral prophylactic mastectomy and 1 extraovarian serous adenocarcinoma after PBSO. Within the entire study collective, a total of 293 have undergone PBSO, with 6 women having an incidental finding of ovarian cancer and STIC respectively (=2.0%; 1.7% gBRCA1 and 0.3% gBRCA2 ). Our data suggests that, particularly regarding ipsilateral secondary cancer (ISC), higher oncological safety can be achieved through mastectomy rather than breast‐conserving surgery (BCS). In the group of patients who had a second breast cancer and were treated with BCS during their first cancer, 18.3% showed an ISC. Within the patients who were first treated with a mastectomy, only 4.3% showed an ISC.

Conclusions

Prophylactic surgeries demonstrate high oncological effectiveness in gPV BRCA1/2 carriers. In particular, mastectomy may provide greater protection against ISC compared with BCS. Further studies will have to be conducted to compare ipsilateral cancer prevalence after breast‐sparing surgery and mastectomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Salpingo-oophorectomyOvarian NeoplasmsGerm-Line MutationBreast NeoplasmsProphylactic MastectomyBRCA2 ProteinBRCA1 ProteinHumansFemaleGermanyMiddle AgedAdultRetrospective StudiesGenetic Predisposition to DiseaseHeterozygoteAgedYoung Adult

Stichwörter der Autor:innen

cancer prevalencegPV BRCA1/2 germline variantshereditary breast and ovarian cancerprophylactic mastectomyprophylactic salpingo‐oophorectomy

Substanzen

BRCA2 ProteinBRCA2 protein, humanBRCA1 protein, humanBRCA1 Protein

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, University Hospital Klinikum Rechts der Isar, Technical University Munich (TUM), Munich, Germany.
  • Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Klinikum Rechts der Isar, Technical University of Munich (TUM), Munich, Germany.

ORCID-Profile: Sara Mendes, Marion Kiechle

Zitieren

APA

Mendes, S., Yahiaoui-Doktor, M., Fallenberg, E. M., Kiechle, M., & Grill, S. (2026). Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo‐Oophorectomy in BRCA1 /2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71691

Vancouver

Mendes S, Yahiaoui-Doktor M, Fallenberg EM, Kiechle M, Grill S. Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo‐Oophorectomy in BRCA1 /2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71691

BibTeX
@article{Mendes2026,
  author = {Mendes, Sara and Yahiaoui-Doktor, Maryam and Fallenberg, Eva Maria and Kiechle, Marion and Grill, Sabine},
  title = {Risk of Breast and Ovarian Cancer After Prophylactic Mastectomy and Salpingo‐Oophorectomy in BRCA1 /2 Germline Variant Carriers: A Retrospective Cohort Study From a Single German Center},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1002/cam4.71691}
}
Kostenlos starten →